Eric Xueyu Chen

Dr. Eric Chen graduated from China Pharmaceutical University (BSc), University of Manitoba (Ph.D.), and University of Toronto (MD).

Dr. Chen is currently an attending physician at the Department of Medical Oncology and Hematology, Princess Margaret Cancer, Toronto, Canada, and an associate professor at the Faculty of Medicine, University of Toronto and an adjunct associate professor at, Faculty of Pharmacy, University of Toronto. Dr. Chen specializes in the treatment of gastrointestinal cancers. His research focuses on the development of new drugs and treatments in cancer treatment, and he has been the principal investigator of dozens of Phase I-III clinical trials. He has published over 140 papers, including on journals such as Journal of Clinical Oncology, JAMA Oncology, Clinical Cancer Research, Annals of Oncology, and Journal of National Cancer Institute.

In addition to his clinical practices, Dr. Chen has been the principal investigator of more than 2000 bioavailability/bioequivalence and drug interaction studies. Dr. Chen is also experienced in good clinical practice audits of FDA, EMA, and Health Canada.